中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 7
Jul.  2023
Turn off MathJax
Article Contents

Risk factors for pulmonary infection after laparoscopic surgery in treatment of hepatocellular carcinoma with liver cirrhosis and portal hypertension

DOI: 10.3969/j.issn.1001-5256.2023.07.012
Research funding:

National Natural Science Foundation of China (31970566)

More Information
  • Corresponding author: ZHANG Ke, zhangke302@sina.com (ORCID: 0000-0002-5006-8674)
  • Received Date: 2022-10-22
  • Accepted Date: 2022-12-01
  • Published Date: 2023-07-20
  •   Objective  To investigate the incidence rate of pulmonary infection after laparoscopic surgery and related risk factors in patients with hepatocellular carcinoma (HCC) comorbid with liver cirrhosis and portal hypertension (PHT).  Methods  A retrospective analysis was performed for the clinical data of 105 HCC patients with liver cirrhosis and PHT who underwent laparoscopic surgery in Beijing Ditan Hospital, Capital Medical University, from January 2017 to February 2022. A total of 30 factors that might cause pulmonary infection were recorded, including general information, disease factors, surgical factors, and postoperative factors. Postoperative recovery was observed and the occurrence of pulmonary infection was recorded. The chi-square test or the Fisher's exact test was used for comparison of categorical data between two groups, and the multivariate logistic regression analysis was used to investigate the independent risk factors for pulmonary infection.  Results  Among the 105 patients, 66 underwent laparoscopic devascularization combined with hepatectomy and 39 underwent laparoscopic devascularization combined with radiofrequency ablation (RFA). The surgery was successful for all patients, with no case of conversion to laparotomy or unscheduled reoperation. No death was observed within 30 days after surgery and during hospitalization, with a median length of hospital stay of 20 days (range 14-25 days). The incidence rate of pulmonary infection was 25.71% (27/105). Smoking (odds ratio [OR]=3.362, 95% confidence interval [CI]: 1.282-8.817, P=0.014), MELD score (OR=3.801, 95%CI: 1.007-14.351, P=0.049), tumor location (OR=1.937, 95%CI: 1.169-3.211, P=0.010), surgical procedure (OR=0.006, 95%CI: 0.001-0.064, P=0.000), intraoperative infusion volume (OR=4.871, 95%CI: 1.211-19.597, P=0.026), and postoperative pleural effusion (OR=9.790, 95%CI: 1.826-52.480, P=0.008) were independent risk factors for pulmonary infection.  Conclusion  There is a relatively high risk of pulmonary infection in HCC patients with liver cirrhosis and PHT undergoing laparoscopic surgery. Postoperative pleural effusion is the high risk factor for pulmonary infection, and devascularization combined with RFA can significantly reduce the risk of pulmonary infection. It is recommended to strengthen preoperative rehabilitation, perioperative liver function maintenance, intraoperative damage control, and goal-oriented fluid therapy and reduce postoperative fluid accumulation in the third space, so as to reduce the incidence rate of pulmonary infection.

     

  • loading
  • [1]
    LI XC, WU YS, CHEN DK, et al. Laparoscopic hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: A systematic review and meta-analysis[J]. Cancer Manag Res, 2019, 11: 5711-5724. DOI: 10.2147/CMAR.S189777.
    [2]
    MARTIN MATEOS R, GARCIA DE LA FILIA MOLINA I, ALBILLOS A. Pre-surgical risk assessment in patients with cirrhosis[J]. Acta Gastroenterol Belg, 2020, 83(3): 449-453.
    [3]
    WEI L, WAN H. Roles of hemodynamic alterations in portal hypertension and cirrhosis[J]. J Clin Hepatol, 2013, 29(4): 308-310. DOI: 10.3969/j.issn.1001-5256.2013.04.019

    魏丽, 万红. 门静脉高压症血流动力学改变的发病机理[J]. 临床肝胆病杂志, 2013, 29(4): 308-310. DOI: 10.3969/j.issn.1001-5256.2013.04.019
    [4]
    GRACIA-SANCHO J, MARRONE G, FERNÁNDEZ-IGLESIAS A. Hepatic microcirculation and mechanisms of portal hypertension[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(4): 221-234. DOI: 10.1038/s41575-018-0097-3.
    [5]
    CHEN WW, WU SD, JIANG W. Research progress on hepato-pulmonary syndrome[J]. Chin J Clin Med, 2018, 25(5): 810-814. DOI: 10.12025/j.issn.1008-6358.2018.20170692.

    陈巍文, 吴盛迪, 蒋炜. 肝肺综合征研究进展[J]. 中国临床医学, 2018, 25(5): 810-814. DOI: 10.12025/j.issn.1008-6358.2018.20170692.
    [6]
    European Association for the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2012, 56(4): 908-943. DOI: 10.1016/j.jhep.2011.12.001.
    [7]
    National Health and Family Planning Commission of the People's Republic of China. Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. J Clin Hepatol, 2017, 33(8): 1419-1431. DOI: 10.3969/j.issn.1001-5256.2017.08.003.

    中华人民共和国国家卫生和计划生育委员会. 原发性肝癌诊疗规范(2017年版)[J]. 临床肝胆病杂志, 2017, 33(8): 1419-1431. DOI: 10.3969/j.issn.1001-5256.2017.08.003.
    [8]
    TAJIRI T, YOSHIDA H, OBARA K, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition)[J]. Dig Endosc, 2010, 22(1): 1-9. DOI: 10.1111/j.1443-1661.2009.00929.x.
    [9]
    KALIL AC, METERSKY ML, KLOMPAS M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society[J]. Clin Infect Dis, 2016, 63(5): e61-e111. DOI: 10.1093/cid/ciw353.
    [10]
    CHEN XM, CHEN XP, ZHENG XJ. Application of predictive nursing intervention in prevention of pulmonary infection in elderly patients with gastric cancer after laparoscopic surgery[J]. J Qilu Nurs, 2019, 25(20): 61-63. DOI: 10.3969/j.issn.1006-7256.2019.20.020.

    陈吓妹, 陈雪萍, 郑休嘉. 预见性护理干预在老年胃癌患者腹腔镜手术后肺部感染预防中的应用[J]. 齐鲁护理杂志, 2019, 25(20): 61-63. DOI: 10.3969/j.issn.1006-7256.2019.20.020.
    [11]
    KARA S, KÜPELI E, YıLMAZ HEB, et al. Predicting pulmonary complications following upper and lower abdominal surgery: ASA vs. ARISCAT risk index[J]. Turk J Anaesthesiol Reanim, 2020, 48(2): 96-101. DOI: 10.5152/TJAR.2019.28158.
    [12]
    ZHANG K, JIANG L, JIA Z, et al. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices[J]. Dig Dis Sci, 2015, 60(5): 1490-1501. DOI: 10.1007/s10620-014-3455-1.
    [13]
    CHEN F, LIU BY, CAO XQ, et al. Construction of early warning score for pulmonary infection after radical gastrectomy for gastric cancer[J]. Chin Nurs Res, 2022, 36(8): 1405-1409. DOI: 10.12102/j.issn.1009-6493.2022.08.016.

    陈芳, 刘丙云, 曹晓倩, 等. 胃癌根治术后肺部感染早期预警评分表的构建[J]. 护理研究, 2022, 36(8): 1405-1409. DOI: 10.12102/j.issn.1009-6493.2022.08.016.
    [14]
    Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical practice guidelines for ERAS in China (2021)(Ⅰ)[J]. Med J Peking Union Med Coll Hosp, 2021, 12(5): 624-631. https://www.cnki.com.cn/Article/CJFDTOTAL-XHYX202105006.htm

    中华医学会外科学分会, 中华医学会麻醉学分会. 中国加速康复外科临床实践指南(2021)(一)[J]. 协和医学杂志, 2021, 12(5): 624-631. https://www.cnki.com.cn/Article/CJFDTOTAL-XHYX202105006.htm
    [15]
    PENG Y, QI XS, GUO XZ. Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis: A systematic review and meta-analysis of observational studies[J]. Medicine, 2016, 95(8): e2877. DOI: 10.1097/MD.0000000000002877.
    [16]
    LUO YX, ZHOU T. Value of systemic immune inflammatory index on predicting the prognosis of patients with decompensated liver cirrhosis[J/CD]. Chin J Liver Dis (Electronic Version), 2021, 13(1): 52-58.

    罗永祥, 周涛. 全身免疫炎症指数对失代偿期肝硬化患者预后的评估价值[J/CD]. 中国肝脏病杂志(电子版), 2021, 13(1): 52-58.
    [17]
    YANG L, KAN QX, GAO J. Relationship between PALBI, MELD, INR and the prognosis of patients with liver cirrhosis combined with upper gastrointestinal hemorrhage and a multivariate study[J]. J Clin Exp Med, 2022, 21(11): 1137-1141. DOI: 10.3969/j.issn.1671-4695.2022.11.005

    杨磊, 阚全香, 高杰. PALBI、MELD及INR值与肝硬化患者合并上消化道出血患者预后的关系及多因素研究[J]. 临床和实验医学杂志, 2022, 21(11): 1137-1141. DOI: 10.3969/j.issn.1671-4695.2022.11.005
    [18]
    JADAUN SS, SAIGAL S. Surgical risk assessment in patients with chronic liver diseases[J]. J Clin Exp Hepatol, 2022, 12(4): 1175-1183. DOI: 10.1016/j.jceh.2022.03.004.
    [19]
    HACKL C, SCHLITT HJ, RENNER P, et al. Liver surgery in cirrhosis and portal hypertension[J]. World J Gastroenterol, 2016, 22(9): 2725-2735. DOI: 10.3748/wjg.v22.i9.2725.
    [20]
    GU ZJ, HU SS, SHI XW, et al. Comparative study of perioperative fluid management in elderly patients with hepatocellular carcinoma complicated with cirrhosis in laparoscopic hepatectomy[J/CD]. Chin Arch Gen Surg(Electronic Edition), 2022, 16(3): 199-204.

    顾竹劼, 胡双双, 师小伟, 等. 老年肝癌合并肝硬化患者围手术期不同液体管理在腹腔镜肝切除术中的对比研究[J/CD]. 中华普通外科学文献(电子版), 2022, 16(3): 199-204.
    [21]
    OUYANG CL, REN B, XU C. Effects of different levels of stroke volume variation following goal-directed fluid therapy on short terms of prognosis in cirrhotic patients with portal hypertension under general anesthesia[C]//Proceedings of the 2016 Chinese Society of Integrated Traditional and Western Medicine Anesthesia (CSIA) Annual Meeting, the Third National Symposium on Integrated Traditional and Western Medicine Anesthesia, and the Founding Conference of the Anesthesia Professional Committee of Henan Institute of Integrated Traditional and Western Medicine, Zhengzhou, 2016: 243-246.

    欧阳春磊, 任波, 徐晨. 目标导向液体治疗对肝硬化门脉高压症手术短期预后的影响[C]//2016中国中西医结合麻醉学会年会暨第三届全国中西医结合麻醉学术研讨会、河南省中西医结合学会麻醉专业委员会成立大会论文汇编. 郑州, 2016: 261-264.
    [22]
    LIU HP. Study on the right side pleural effusion after primary liver cancer resection of part of the causes and countermeasures[J]. World Latest Med Inf, 2015, 15(48): 36, 39. https://www.cnki.com.cn/Article/CJFDTOTAL-WMIA201548026.htm

    刘含平. 探讨原发性肝癌切除术后右侧胸水的部分成因及对策[J]. 世界最新医学信息文摘, 2015, 15(48): 36, 39. https://www.cnki.com.cn/Article/CJFDTOTAL-WMIA201548026.htm
    [23]
    LAI C, JIN RN, LIANG X, et al. Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma[J]. J Zhejiang Univ Sci B, 2016, 17(3): 236-246. DOI: 10.1631/jzus.B1500322.
    [24]
    JANY B, WELTE T. Pleural effusion in adults-etiology, diagnosis, and treatment[J]. Dtsch Arztebl Int, 2019, 116(21): 377-386. DOI: 10.3238/arztebl.2019.0377.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (363) PDF downloads(39) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return